Literature DB >> 22437964

Motor signs in the prodromal phase of Parkinson's disease.

Walter Maetzler1, Jeffrey M Hausdorff.   

Abstract

Relatively subtle deterioration of the motor system likely occurs well before the patient meets established motor criteria for a clinical diagnosis of Parkinson's disease; ie, the occurrence of at least 2 of the cardinal motor deficits: bradykinesia, rigidity, tremor, and/or postural instability. Powerful compensatory mechanisms may mask these clinical symptoms and make them difficult to identify and evaluate in the earliest stages of the illness. This review summarizes our current knowledge of motor signs that are thought to occur in the prodromal phase of Parkinson's disease and suggests how motor assessment batteries could be designed to detect these subclinical motor deficits with a high degree of accuracy and sensitivity.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22437964     DOI: 10.1002/mds.24973

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  24 in total

1.  Arm swing as a potential new prodromal marker of Parkinson's disease.

Authors:  Anat Mirelman; Hagar Bernad-Elazari; Avner Thaler; Eytan Giladi-Yacobi; Tanya Gurevich; Mali Gana-Weisz; Rachel Saunders-Pullman; Deborah Raymond; Nancy Doan; Susan B Bressman; Karen S Marder; Roy N Alcalay; Ashwini K Rao; Daniela Berg; Kathrin Brockmann; Jan Aasly; Bjørg Johanne Waro; Eduardo Tolosa; Dolores Vilas; Claustre Pont-Sunyer; Avi Orr-Urtreger; Jeffrey M Hausdorff; Nir Giladi
Journal:  Mov Disord       Date:  2016-10       Impact factor: 10.338

2.  Do subjects with minimal motor features have prodromal Parkinson disease?

Authors:  Yaping Chu; Aron S Buchman; C Warren Olanow; Jeffrey H Kordower
Journal:  Ann Neurol       Date:  2018-03-10       Impact factor: 10.422

Review 3.  Loss of gait control assessed by cognitive-motor dual-tasks: pros and cons in detecting people at risk of developing Alzheimer's and Parkinson's diseases.

Authors:  Maroua Belghali; Nathalie Chastan; Fabien Cignetti; Damien Davenne; Leslie M Decker
Journal:  Geroscience       Date:  2017-05-27       Impact factor: 7.713

Review 4.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

5.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

6.  Application of the Movement Disorder Society prodromal criteria in healthy G2019S-LRRK2 carriers.

Authors:  Anat Mirelman; Rachel Saunders-Pullman; Roy N Alcalay; Shiran Shustak; Avner Thaler; Tanya Gurevich; Deborah Raymond; Helen Mejia-Santana; Martha Orbe Reilly; Laurie Ozelius; Lorraine Clark; Mali Gana-Weisz; Anat Bar-Shira; Avi Orr-Utreger; Susan B Bressman; Karen Marder; Nir Giladi
Journal:  Mov Disord       Date:  2018-03-30       Impact factor: 10.338

7.  Impaired synergic control of posture in Parkinson's patients without postural instability.

Authors:  Ali Falaki; Xuemei Huang; Mechelle M Lewis; Mark L Latash
Journal:  Gait Posture       Date:  2015-12-24       Impact factor: 2.840

Review 8.  The motor prodromes of parkinson's disease: from bedside observation to large-scale application.

Authors:  C Simonet; A Schrag; A J Lees; A J Noyce
Journal:  J Neurol       Date:  2019-12-04       Impact factor: 4.849

9.  Mild parkinsonian signs in the elderly--is there an association with PD? Crossectional findings in 992 individuals.

Authors:  Stefanie Lerche; Markus Hobert; Kathrin Brockmann; Isabel Wurster; Alexandra Gaenslen; Sandra Hasmann; Gerhard W Eschweiler; Walter Maetzler; Daniela Berg
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Instrumented functional reach test differentiates individuals at high risk for Parkinson's disease from controls.

Authors:  Sandra E Hasmann; Daniela Berg; Markus A Hobert; David Weiss; Ulrich Lindemann; Johannes Streffer; Inga Liepelt-Scarfone; Walter Maetzler
Journal:  Front Aging Neurosci       Date:  2014-10-24       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.